Cargando…

A Randomised Controlled Trial of Intravenous Zoledronic Acid in Malignant Pleural Disease: A Proof of Principle Pilot Study

INTRODUCTION: Animal studies have shown Zoledronic Acid (ZA) may diminish pleural fluid accumulation and tumour bulk in malignant pleural disease (MPD). We performed a pilot study to evaluate its effects in humans. METHODS: We undertook a single centre, double-blind, placebo-controlled trial in adul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Clive, Amelia O., Hooper, Clare E., Edey, Anthony J., Morley, Anna J., Zahan-Evans, Natalie, Hall, David, Lyburn, Iain, White, Paul, Braybrooke, Jeremy P., Sequeiros, Iara, Lyen, Stephen M., Milton, Tim, Kahan, Brennan C., Maskell, Nick A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364455/ https://www.ncbi.nlm.nih.gov/pubmed/25781025 http://dx.doi.org/10.1371/journal.pone.0118569

Ejemplares similares

Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score
por: Clive, Amelia O, et al.
Publicado: (2014)

Pleural Fluid Adenosine Deaminase (Pfada) in the Diagnosis of Tuberculous Effusions in a Low Incidence Population
por: Arnold, David T., et al.
Publicado: (2015)

Lymphocyte predominance in blood, pleural fluid, and tumour stroma; a prognostic marker in pleural mesothelioma
por: De Fonseka, Duneesha, et al.
Publicado: (2022)

The efficacy of indwelling pleural catheter placement versus placement plus talc sclerosant in patients with malignant pleural effusions managed exclusively as outpatients (IPC-PLUS): study protocol for a randomised controlled trial
por: Bhatnagar, Rahul, et al.
Publicado: (2015)

Randomised controlled trial to compare the diagnostic yield of positron emission tomography CT (PET-CT) TARGETed pleural biopsy versus CT-guided pleural biopsy in suspected pleural malignancy (TARGET trial)
por: de Fonseka, Duneesha, et al.
Publicado: (2018)

Zoledronic acid in the management of mesothelioma - a feasibility study (Zol-A Trial): study protocol for a randomised controlled trial
por: de Fonseka, Duneesha, et al.
Publicado: (2018)

Home intravenous antibiotic treatment for acute pulmonary exacerbations in cystic fibrosis — Is it good for the patient?
por: Sequeiros, Iara Maria, et al.
Publicado: (2009)

The role of serum procalcitonin in establishing the diagnosis and prognosis of pleural infection
por: Dixon, Giles, et al.
Publicado: (2017)

Interventions for the management of malignant pleural effusions: an updated network meta-analysis
por: Dipper, Alex, et al.
Publicado: (2021)

Intravenous Zoledronate for a Patient with Paget's Disease
por: Kim, Ki-Choul
Publicado: (2014)

The South West Area Mesothelioma and Pemetrexed trial: a multicentre prospective observational study evaluating novel markers of chemotherapy response and prognostication
por: Hooper, C E, et al.
Publicado: (2015)

The effect of chemotherapy on health-related quality of life in mesothelioma: results from the SWAMP trial
por: Arnold, D T, et al.
Publicado: (2015)

Six monthly intravenous zoledronic acid in childhood osteoporosis
por: Munns, CF, et al.
Publicado: (2013)

THU443 Acute Iridocyclitis Associated With Intravenous Zoledronic Acid
por: Ankireddypalli, Anvitha Reddy, et al.
Publicado: (2023)

Pleural Fluid suPAR Levels Predict the Need for Invasive Management in Parapneumonic Effusions
por: Arnold, David T., et al.
Publicado: (2020)

A pilot study of zoledronic acid in the treatment of patients with advanced malignant pleural mesothelioma
por: Jamil, Muhammad Omer, et al.
Publicado: (2017)

Treatment of Transient Osteoporosis of the Hip with Intravenous Zoledronate - A Case Report -
por: Seok, Hyun, et al.
Publicado: (2011)

Intravenous zoledronic acid for the treatment of osteoporosis: The evidence of its therapeutic effect
por: Lewiecki, E Michael
Publicado: (2010)

Acute Iridocyclitis Associated With Intravenous Zoledronic Acid: A Case Report
por: Ankireddypalli, Anvitha R, et al.
Publicado: (2023)

A trial of intra-pleural bacterial immunotherapy in malignant pleural mesothelioma (TILT) — a randomised feasibility study using the trial within a cohort (TwiC) methodology
por: Bibby, Anna C., et al.
Publicado: (2022)

Intravenous zoledronate for postmenopausal women with osteopenia and osteoporosis: a systematic review and metanalysis
por: Gazoni, Fernanda Martins, et al.
Publicado: (2023)

BTS guideline for the investigation and management of malignant pleural mesothelioma
por: Woolhouse, Ian, et al.
Publicado: (2018)

Providing safe and effective pleural medicine services in the UK: an aspirational statement from UK pleural physicians
por: Evison, Matthew, et al.
Publicado: (2018)

Novel pleural-bladder pump in malignant pleural effusions: from animal model to man
por: Astoul, Philippe, et al.
Publicado: (2020)

Favorable therapeutic response of osteoporosis patients to treatment with intravenous zoledronate compared with oral alendronate
por: Al-Bogami, Mohammed M., et al.
Publicado: (2015)

Toxicity of zoledronic acid after intravenous administration: A retrospective study of 95 dogs
por: Brewer, David John, et al.
Publicado: (2021)

ODP107 Oral Ulcerations, A Rare Side Effect of Intravenous Zoledronic Acid
por: Del Mar Morales Hernandez, Maria, et al.
Publicado: (2022)

Standard pleural interventions are not high-risk aerosol generating procedures
por: Arnold, David T., et al.
Publicado: (2021)

Ancillary Diagnostic Investigations in Malignant Pleural Mesothelioma
por: Dipper, Alex, et al.
Publicado: (2021)

Corticosteroids for Pleural Infection: Should We STOPPE Studying?
por: Arnold, David T., et al.
Publicado: (2022)

Prophylactic radiotherapy for the prevention of procedure-tract metastases after surgical and large-bore pleural procedures in malignant pleural mesothelioma (SMART): a multicentre, open-label, phase 3, randomised controlled trial
por: Clive, Amelia O, et al.
Publicado: (2016)

Time associated with intravenous zoledronic acid administration in patients with breast or prostate cancer and bone metastasis
por: Richhariya, Akshara, et al.
Publicado: (2012)

Call to action: a five nations consensus on the use of intravenous zoledronate after hip fracture
por: Johansen, Antony, et al.
Publicado: (2023)

Natalizumab-induced pneumonitis
por: Kaninia, Stefania, et al.
Publicado: (2021)

Epidemiology of pleural empyema in English hospitals and the impact of influenza
por: Arnold, David T., et al.
Publicado: (2021)

Protocol for the surgical and large bore procedures in malignant pleural mesothelioma and radiotherapy trial (SMART Trial): an RCT evaluating whether prophylactic radiotherapy reduces the incidence of procedure tract metastases
por: Clive, Amelia O, et al.
Publicado: (2015)

Histomorphometric Evaluation of Peri-Implant Bone Response to Intravenous Administration of Zoledronate (Zometa(®)) in an Osteoporotic Rat Model
por: Basudan, Amani M., et al.
Publicado: (2020)

SUN-386 Treatment Outcomes of Intravenous Zoledronic Acid vs Oral Alendronate in Postmenopausal Women with Osteoporosis
por: Pyone, Zar Chi, et al.
Publicado: (2020)

Intravenous Zoledronate 4 mg for the treatment of post-menopausal osteoporosis: A prospective open-labeled study
por: Arunthanachaikul, Thunyawarin, et al.
Publicado: (2021)

Exploring the characteristics of patients with mesothelioma who chose active symptom control over chemotherapy as first-line treatment: a prospective, observational, single centre study
por: Bibby, Anna C., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_labjkppav2otte2ri8f7vj8aef